Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Knightscope
Sponsored
content by Knightscope
MA
MarketJar
Community Contributor
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.
View narrative
US$12.00
FV
50.7% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
10
users have liked this narrative
1
users have commented on this narrative
44
users have followed this narrative
8 days ago
author updated this narrative
Figma
TI
TickerTickle
Community Contributor
Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform
Watching Figma Grow Up I’ve been using Figma almost every single day for the past five years. As a product designer, it’s been my main tool for designing interfaces, testing and prototyping ideas, and also for working together with teams in different countries and time zones.
View narrative
US$65.70
FV
8.5% overvalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
19
users have followed this narrative
Updated
narrative
Sleep Cycle
MA
Mandelman
Community Contributor
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.
View narrative
SEK 38.04
FV
18.4% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
2
users have commented on this narrative
37
users have followed this narrative
Updated
narrative
JB Hi-Fi
RO
Robbo
Community Contributor
Has JB Hi-Fi Lost Its Point of Difference?
I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.
View narrative
AU$76.00
FV
51.6% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
1
users have commented on this narrative
11
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
ITM Power
AN
AnalystHighTarget
Consensus Narrative from 10 Analysts
Global Decarbonization Will Unlock Expansive Hydrogen Adoption
Key Takeaways Manufacturing innovations and new business models are set to sharply improve margins, recurring revenues, and customer adoption across industrial sectors. Policy support, technology advancements, and first-mover advantages position ITM Power for substantial market share growth and long-term expansion as green hydrogen demand accelerates.
View narrative
UK£2.43
FV
71.7% undervalued
intrinsic discount
64.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Genius Group
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Easing Legal Hurdles Will Unleash AI Edtech And Bitcoin Expansion
Key Takeaways Lifting of legal restrictions and legal resolutions may boost platform growth, product launches, and financial stability while lowering extraordinary costs and supporting future earnings potential. Expansion of AI-driven, personalized learning and unified edtech offerings under the Genius brand is expected to increase user engagement, recurring revenue, and global market reach.
View narrative
US$4.30
FV
78.1% undervalued
intrinsic discount
54.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
1 day ago
author updated this narrative
GeneDx Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Expanding Pediatric Genomics Will Transform Rare Disease Diagnostics
Key Takeaways Accelerating adoption of genomics in pediatrics and enhanced AI platforms drive growth, efficiency, and margin improvement while reinforcing competitive advantage. Increasing reimbursement, enriched rare disease datasets, and global biopharma partnerships support recurring revenues, premium pricing, and high barriers to entry.
View narrative
US$115.29
FV
11.9% overvalued
intrinsic discount
19.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
20
users have followed this narrative
1 day ago
author updated this narrative
Altice USA
AN
AnalystHighTarget
Consensus Narrative from 15 Analysts
Accelerated Fiber Expansion Will Spark Premium Broadband Demand
Key Takeaways Accelerated fiber and AI-driven operational gains, along with innovative financing, are positioning the company for significantly stronger revenue and margin performance. Expansion into underpenetrated markets and rapid adoption of premium products are creating new high-margin revenue streams and enhancing long-term growth potential.
View narrative
US$5.37
FV
56.2% undervalued
intrinsic discount
-1.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
GoodRx Holdings
AN
AnalystHighTarget
Consensus Narrative from 14 Analysts
Digital Transformation And Aging Trends Will Expand Affordable Prescription Access
Key Takeaways Deeper integration into pharmacy systems and expanded direct-to-consumer offerings are expected to drive higher user retention, transaction frequency, and operating leverage. Rapid growth in the subscription market and unique pharmacy partnerships position GoodRx for outsized revenue and margin expansion with recurring and defensible income streams.
View narrative
US$7.00
FV
37.7% undervalued
intrinsic discount
7.14%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Syndax Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Revuforj And Niktimvo Will Extend Precision Oncology Reach
Key Takeaways Expanding drug adoption, earlier-line usage, and new regulatory approvals are set to drive broader market access and boost long-term revenue growth. Strong late-stage pipeline, fixed costs, and leading positions in precision oncology create operating leverage and sustained momentum for multi-year profitability.
View narrative
US$36.36
FV
55.1% undervalued
intrinsic discount
90.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
1 day ago
author updated this narrative
Apyx Medical
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Minimally Invasive Aesthetic Procedures Will Expand International Markets
Key Takeaways Strong adoption of AYON system and expansion into China are expected to accelerate revenue growth and increase international market presence. Strategic hires and cost reduction initiatives enhance sales execution, operational efficiency, and support margin expansion and long-term earnings improvement.
View narrative
US$4.00
FV
49.5% undervalued
intrinsic discount
12.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
ADC Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Clinical Trial Successes And Shifting Demographics Will Transform Oncology
Key Takeaways Strong clinical data and precision medicine strategies position the company for broader market adoption and increased revenues in expanding oncology segments. Cost-cutting measures and strategic partnerships are set to improve margins, extend cash runway, and reduce financial risk.
View narrative
US$8.20
FV
60.4% undervalued
intrinsic discount
38.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
1 day ago
author updated this narrative
Superior Plus
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Electrification Will Erode Propane Markets While Diversification Will Restore Resilience
Key Takeaways Electrification, alternative heating, and urbanization trends threaten long-term propane demand, revenue growth, and core market stability. Reliance on fossil fuels exposes the company to regulatory risk, higher compliance costs, and pressure on net margins as energy standards tighten.
View narrative
CA$7.50
FV
3.2% undervalued
intrinsic discount
3.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Value any company in seconds
Popular companies